article · Alzheimer s & Dementia
These findings demonstrate that myricetin has the potential to counteract the neurotoxic effects of atrazine, providing a promising avenue for developing therapeutic interventions for environmental toxin-induced cognitive impairments associated with Parkinson's Disease.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/alz70855_096935
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
